The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125666961 12566696 1 I 20160226 20160713 20160718 20160718 EXP US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-058810 BRISTOL MYERS SQUIBB 66.38 YR F Y 68.50000 KG 20160718 OT US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125666961 12566696 1 PS GLUCOVANCE GLYBURIDEMETFORMIN HYDROCHLORIDE 1 Unknown UNK U 21178 FILM-COATED TABLET
125666961 12566696 2 SS TANZEUM ALBIGLUTIDE 1 Subcutaneous 50 MG, UNK N 0 50 MG SOLUTION FOR INJECTION
125666961 12566696 3 SS METFORMIN METFORMIN HYDROCHLORIDE 1 Unknown UNK U 0
125666961 12566696 4 SS TOUJEO INSULIN GLARGINE 1 Unknown UNK U 0
125666961 12566696 5 SS NOVOLOG INSULIN ASPART 1 Unknown UNK U 0
125666961 12566696 6 SS LANTUS INSULIN GLARGINE 1 Unknown UNK U 0
125666961 12566696 7 SS LIRAGLUTIDE LIRAGLUTIDE 1 Unknown UNK U 0
125666961 12566696 8 C ATORVASTATIN ATORVASTATIN 1 Unknown U 0
125666961 12566696 9 C ALBUTEROL /00139501/ ALBUTEROL 1 Unknown U 0
125666961 12566696 10 C WELLBUTRIN BUPROPION HYDROCHLORIDE 1 Unknown U 0
125666961 12566696 11 C LEVOTHYROXINE. LEVOTHYROXINE 1 Unknown U 0
125666961 12566696 12 C SPIRIVA TIOTROPIUM BROMIDE MONOHYDRATE 1 Unknown U 0
125666961 12566696 13 C ASPIRIN /00002701/ ASPIRIN 1 Unknown U 0
125666961 12566696 14 C DIOVAN VALSARTAN 1 Unknown U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125666961 12566696 1 Type 2 diabetes mellitus
125666961 12566696 2 Diabetes mellitus
125666961 12566696 3 Diabetes mellitus
125666961 12566696 4 Diabetes mellitus
125666961 12566696 5 Diabetes mellitus
125666961 12566696 6 Diabetes mellitus
125666961 12566696 7 Diabetes mellitus
125666961 12566696 8 Product used for unknown indication
125666961 12566696 9 Product used for unknown indication
125666961 12566696 10 Product used for unknown indication
125666961 12566696 11 Product used for unknown indication
125666961 12566696 12 Product used for unknown indication
125666961 12566696 13 Product used for unknown indication
125666961 12566696 14 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
125666961 12566696 OT
125666961 12566696 LT

Reactions reported

Event ID CASEID DRUG REC ACT PT
125666961 12566696 Abdominal pain
125666961 12566696 Adenocarcinoma
125666961 12566696 Back pain
125666961 12566696 Carbohydrate antigen 19-9 increased
125666961 12566696 Gastrointestinal carcinoma
125666961 12566696 Hepatobiliary cancer
125666961 12566696 Pancreatic carcinoma metastatic

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125666961 12566696 1 201009 201106 0
125666961 12566696 2 201511 20160524 0
125666961 12566696 3 2011 0
125666961 12566696 4 201202 0
125666961 12566696 5 201202 0
125666961 12566696 6 201202 0
125666961 12566696 7 201112 201510 0